StockDuty ← Dashboard Oct 31, 2026 01:24 AM ET
SignalCorporate

REGN Q3 Earnings Beat on Dupixent Profits & Eylea HD Growth, Stock Up

REGN Q3 earnings beat driven by Dupixent profits and Eylea HD growth, lifting stock.

What happened: Regeneron $REGN reported third-quarter 2026 adjusted EPS of $20.07, beating the Zacks Consensus Estimate of $16.08, on revenue of $5.12 billion. The stock is trading up after the results. Key numbers: EPS $20.07 vs estimate $16.08, up 70% from $11.83 a year ago. Revenue $5.12 billion vs estimate $4.55 billion, up 36%. Eylea HD U.S. Why it matters: Strong Dupixent profit contributions and Eylea HD and Libtayo momentum drove the beat, while declining legacy Eylea sales remain a headwind. Regeneron raised its 2026 gross margin outlook to approximately 86% from 84-85%. Market: +13.3% today ($927.89), +19.8% YTD, 4.0x vol — as of 23:45 UTC Verified: Q3_2026 (Oct 30) EPS $20.07 vs $16.25 est, +23.5% beat; next print ~Jan 29
Regeneron $REGN reported third-quarter 2026 adjusted EPS of $20.07, beating the Zacks Consensus Estimate of $16.08, on revenue of $5.12 billion. The stock is trading up after the results.
Strong Dupixent profit contributions and Eylea HD and Libtayo momentum drove the beat, while declining legacy Eylea sales remain a headwind. Regeneron raised its 2026 gross margin outlook to approximately 86% from 84-85%. Market: +13.3% today ($927.89), +19.8% YTD, 4.0x vol — as of 23:45 UTC Verified: Q3_2026 (Oct 30) EPS $20.07 vs $16.25 est, +23.5% beat; next print ~Jan 29
Sources